Global cardiopulmonary bypass equipment market is estimated to be valued at US$ 205.1 Mn in 2024 and is expected to reach USD 246.2 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 2.6 % from 2024 to 2031.
To learn more about this report, request sample copy
Global cardiopulmonary bypass equipment market is expected to witness a steady growth over the forecast period due to increasing prevalence of cardiovascular diseases and growing demand for minimally invasive surgeries. Moreover, advancement in clinical research for improving bypass equipment and rising healthcare expenditure can also drive the market growth during this period. However, high costs associated with cardiopulmonary bypass surgeries and lack of awareness in developing regions are expected to hinder the market growth.
Rising Burden of Cardiovascular Diseases
Rising prevalence of cardiovascular diseases across the world can boost demand for cardiopulmonary bypass equipment. Cardiovascular diseases are the leading causes of mortality worldwide. According to the data published by the World Health Organization, cardiovascular diseases accounted for over 17 million deaths in 2015, which is estimated to grow to over 23 million by 2030. Growing geriatric population base can increase the risk of various heart conditions. Moreover, changing lifestyles and increasing consumption of unhealthy diets have also contributed to rising incidence of diseases like coronary artery disease and heart failure. This has significantly boosted the number of open-heart surgeries and other cardiac procedures performed annually. Cardiopulmonary bypass is essential for most of these surgical interventions. For Instance, according to the World Heart Federation in 2024, global deaths from cardiovascular disease (CVD) had increased from 12.1 million in 1990 to 20.5 million in 2021, making CVD the leading cause of death worldwide in 2021, with the majority occurring in low- and middle-income countries (LMICs). The World Heart Report, released at the 2023 World Heart Summit, offers the first comprehensive analysis of CVD risk and mortality data globally, thus, highlighting significant regional disparities. Despite an overall increase in CVD deaths over the past three decades, the global CVD death rate had decreased from 354.5 to 239.9 deaths per 100,000 people between 1990 and 2019, with high-income countries experiencing the most rapid decline.
Technological Advancements
Constant technological advancements can boost demand for cardiopulmonary bypass equipment. Vendors are continually focusing on developing novel product ranges with added features to improve therapeutic outcomes. For instance, new cardiopulmonary bypass machines feature miniaturized components for minimal invasiveness. Advanced bubble oxygenators enables homogeneous gas transfer without affecting blood flow regulation. Next-generation heart-lung machines are outfitted with enhanced safety alarms and automated regulatory mechanisms. Such innovations allows for more efficient and controlled CBP procedures. The introduction of affordable equipment variants increases access in price-sensitive low and middle-income markets. The integration of virtual technologies like artificial intelligence and machine learning improves intra-operative decision making and reduce manual errors. Rising investments by players towards R&D of more innovative solutions can offer new growth opportunities.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients